9DAZ image
Deposition Date 2024-08-23
Release Date 2025-07-09
Last Version Date 2025-09-17
Entry Detail
PDB ID:
9DAZ
Title:
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus. Complex of fAPN with FCoV-23 RBD
Biological Source:
Source Organism:
Felis catus (Taxon ID: 9685)
Feline coronavirus (Taxon ID: 12663)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.50 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Aminopeptidase N,Immunoglobulin gamma-1 heavy chain
Gene (Uniprot):ANPEP
Chain IDs:A, C
Chain Length:1184
Number of Molecules:2
Biological Source:Felis catus
Polymer Type:polypeptide(L)
Molecule:Spike glycoprotein
Chain IDs:B, D
Chain Length:213
Number of Molecules:2
Biological Source:Feline coronavirus
Primary Citation
Loss of FCoV-23 spike domain 0 enhances fusogenicity and entry kinetics.
Nature 645 235 243 (2025)
PMID: 40634609 DOI: 10.1038/s41586-025-09155-z

Abstact

The ability of coronaviruses to recombine and cross species barriers affects human and animal health globally and is a pandemic threat1,2. FCoV-23 is a recently emerged, highly pathogenic recombinant coronavirus responsible for a widespread outbreak of feline infectious peritonitis. Here we report cryogenic electron microscopy structures of two FCoV-23 spike isoforms that correspond to the in-host loss of domain 0 observed in clinical samples. The loss of domain 0 markedly enhances the fusogenicity and kinetics of entry into cells and possibly enables biotype switching and lethality. We show that FCoV-23 can use several aminopeptidase N orthologues as receptors and reveal the molecular determinants of receptor species tropism, including a glycan that modulates human receptor engagement. We define antigenic relationships among alphacoronaviruses that infect humans and other mammalian species and identify a cross-reactive alphacoronavirus monoclonal antibody that inhibits FCoV-23 entry. Our results pave the way for the development of vaccines and therapeutics that target this highly pathogenic virus.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback